Will there ever be a universal Staphylococcus aureus vaccine?

References

• Nanra JS, Timofeyeva Y, Buitrago SM, Sellman BR, Dilts DA, Fink P, et al. Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design. Vaccine 2009; 27:3276 - 80; http://dx.doi.org/10.1016/j.vaccine.2009.01.062; PMID: 19200819
   PubMed Web of Science ®Google Scholar
• Golubchik T, Batty EM, Miller RR, Farr H, Young BC, Larner-Svensson H, et al. Within-host evolution of Staphylococcus aureus during asymptomatic carriage. PLoS One 2013; 8:e61319; http://dx.doi.org/10.1371/journal.pone.0061319; PMID: 23658690
   PubMedGoogle Scholar
• Nethercott C, Mabbett AN, Totsika M, Peters P, Ortiz JC, Nimmo GR, et al. Molecular Characterization of Endocarditis-Associated Staphylococcus aureus. J Clin Microbiol 2013; 51:2131 - 8; http://dx.doi.org/10.1128/JCM.00651-13; PMID: 23616460
   PubMed Web of Science ®Google Scholar
• Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus.. Infect Immun 2002; 70:4987 - 96; http://dx.doi.org/10.1128/IAI.70.9.4987-4996.2002; PMID: 12183545
   PubMed Web of Science ®Google Scholar
• Bonventre PF, Linnemann C, Weckbach LS, Staneck JL, Buncher CR, Vigdorth E, et al. Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis 1984; 150:662 - 6; http://dx.doi.org/10.1093/infdis/150.5.662; PMID: 6491377
   PubMed Web of Science ®Google Scholar
• Christensson B, Hedström SA. Serological response to toxic shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls. Acta Pathol Microbiol Immunol Scand B 1985; 93:87 - 90; PMID: 4013745
   PubMedGoogle Scholar
• Johnson HM, Russell JK, Pontzer CH. Staphylococcal enterotoxin microbial superantigens. FASEB J 1991; 5:2706 - 12; PMID: 1916093
   PubMed Web of Science ®Google Scholar
• Novick RP. Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus.. Plasmid 2003; 49:93 - 105; http://dx.doi.org/10.1016/S0147-619X(02)00157-9; PMID: 12726763
   PubMed Web of Science ®Google Scholar
• Dreisbach A, Hempel K, Buist G, Hecker M, Becher D, van Dijl JM. Profiling the surfacome of Staphylococcus aureus.. Proteomics 2010; 10:3082 - 96; http://dx.doi.org/10.1002/pmic.201000062; PMID: 20662103
   PubMed Web of Science ®Google Scholar
• Dreisbach A, van der Kooi-Pol MM, Otto A, Gronau K, Bonarius HP, Westra H, et al. Surface shaving as a versatile tool to profile global interactions between human serum proteins and the Staphylococcus aureus cell surface. Proteomics 2011; 11:2921 - 30; http://dx.doi.org/10.1002/pmic.201100134; PMID: 21674804
   PubMed Web of Science ®Google Scholar
• Klevens RM, Edwards JR, Gaynes RP, National Nosocomial Infections Surveillance System. The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin Infect Dis 2008; 47:927 - 30; http://dx.doi.org/10.1086/591698; PMID: 18752440
   PubMed Web of Science ®Google Scholar
• Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al, Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763 - 71; http://dx.doi.org/10.1001/jama.298.15.1763; PMID: 17940231
   PubMed Web of Science ®Google Scholar
• Forstner C, Dungl C, Tobudic S, Mitteregger D, Lagler H, Burgmann H. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence. Clin Microbiol Infect 2013; 19:E291 - 7; http://dx.doi.org/10.1111/1469-0691.12169; PMID: 23490021
   PubMed Web of Science ®Google Scholar
• Peyrani P, Allen M, Wiemken TL, Haque NZ, Zervos MJ, Ford KD, et al, IMPACT-HAP Study Group. Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. Clin Infect Dis 2011; 53:766 - 71; http://dx.doi.org/10.1093/cid/cir541; PMID: 21880581
   PubMed Web of Science ®Google Scholar
• de Kraker MEA, Davey PG, Grundmann H, BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011; 8:e1001104; http://dx.doi.org/10.1371/journal.pmed.1001104; PMID: 22022233
   PubMed Web of Science ®Google Scholar
• Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011; 11:30 - 8; http://dx.doi.org/10.1016/S1473-3099(10)70258-9; PMID: 21126917
   PubMed Web of Science ®Google Scholar
• Mediavilla JR, Chen L, Mathema B, Kreiswirth BN. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol 2012; 15:588 - 95; http://dx.doi.org/10.1016/j.mib.2012.08.003; PMID: 23044073
   PubMed Web of Science ®Google Scholar
• Malachowa N, Kobayashi SD, DeLeo FR. Community-associated methicillin-resistant Staphylococcus aureus and athletes. Phys Sportsmed 2012; 40:13 - 21; http://dx.doi.org/10.3810/psm.2012.05.1960; PMID: 22759601
   PubMed Web of Science ®Google Scholar
• Otto M. MRSA virulence and spread. Cell Microbiol 2012; 14:1513 - 21; http://dx.doi.org/10.1111/j.1462-5822.2012.01832.x; PMID: 22747834
   PubMed Web of Science ®Google Scholar
• Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, et al. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun 2006; 74:2215 - 23; http://dx.doi.org/10.1128/IAI.74.4.2215-2223.2006; PMID: 16552052
   PubMed Web of Science ®Google Scholar
• Josefsson E, Hartford O, O’Brien L, Patti JM, Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 2001; 184:1572 - 80; http://dx.doi.org/10.1086/324430; PMID: 11740733
   PubMed Web of Science ®Google Scholar
• Welch PG, Fattom A, Moore J Jr., Schneerson R, Shiloach J, Bryla DA, et al. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. J Am Soc Nephrol 1996; 7:247 - 53; PMID: 8785394
   PubMed Web of Science ®Google Scholar
• Fattom AI, Sarwar J, Ortiz A, Naso R. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun 1996; 64:1659 - 65; PMID: 8613375
   PubMed Web of Science ®Google Scholar
• Weisman LE, Fischer GW, Thackray HM, Johnson KE, Schuman RF, Mandy GT, et al. Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults. Int Immunopharmacol 2009; 9:639 - 44; http://dx.doi.org/10.1016/j.intimp.2009.02.008; PMID: 19268719
   PubMed Web of Science ®Google Scholar
• Burnie JP, Matthews RC, Carter T, Beaulieu E, Donohoe M, Chapman C, et al. Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun 2000; 68:3200 - 9; http://dx.doi.org/10.1128/IAI.68.6.3200-3209.2000; PMID: 10816464
   PubMed Web of Science ®Google Scholar
• Proctor RA. Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis 2012; 54:1179 - 86; http://dx.doi.org/10.1093/cid/cis033; PMID: 22354924
   PubMed Web of Science ®Google Scholar
• Jansen KU, Girgenti DQ, Scully IL, Anderson AS. Vaccine review: “Staphyloccocus aureus vaccines: Problems and prospects”. Vaccine 2013; 31:2723 - 30; http://dx.doi.org/10.1016/j.vaccine.2013.04.002; PMID: 23624095
   PubMed Web of Science ®Google Scholar
• Fowler VG, Allen KB, Moreira ED, Moustafa M, Isgro F, Boucher HW, et al. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA 2013; 309:1368 - 78; http://dx.doi.org/10.1001/jama.2013.3010; PMID: 23549582
   PubMed Web of Science ®Google Scholar
• Spellberg B, Daum R. Development of a vaccine against Staphylococcus aureus.. Semin Immunopathol 2012; 34:335 - 48; http://dx.doi.org/10.1007/s00281-011-0293-5; PMID: 22080194
   PubMed Web of Science ®Google Scholar
• Daum RS, Spellberg B. Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis 2012; 54:560 - 7; http://dx.doi.org/10.1093/cid/cir828; PMID: 22186773
   PubMed Web of Science ®Google Scholar
• Thomsen I, Dudney H, Creech CB. Searching for the holy grail of a staphylococcal vaccine. Hum Vaccin 2010; 6:1068 - 70; http://dx.doi.org/10.4161/hv.6.12.12917; PMID: 21150276
   PubMed Web of Science ®Google Scholar
• Avery TR, Kleinman KP, Klompas M, Aschengrau A, Huang SS. Inclusion of 30-day postdischarge detection triples the incidence of hospital-onset methicillin-resistant Staphylococcus aureus.. Infect Control Hosp Epidemiol 2012; 33:114 - 21; http://dx.doi.org/10.1086/663714; PMID: 22227979
   PubMed Web of Science ®Google Scholar
• Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36:281 - 5; http://dx.doi.org/10.1086/345955; PMID: 12539068
   PubMed Web of Science ®Google Scholar
• Duffy J, Dumyati G, Bulens S, Namburi S, Gellert A, Fridkin SK, et al. Community-onset invasive methicillin-resistant Staphylococcus aureus infections following hospital discharge. Am J Infect Control 2013; In press http://dx.doi.org/10.1016/j.ajic.2012.10.020; PMID: 23394888
   PubMed Web of Science ®Google Scholar
• Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB. Natural antibodies in normal human sera inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy. Clin Infect Dis 2012; 205:1709 - 18
   Google Scholar
• Skurnik D, Merighi M, Grout M, Gadjeva M, Maira-Litran T, Ericsson M, et al. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest 2010; 120:3220 - 33; http://dx.doi.org/10.1172/JCI42748; PMID: 20739753
   PubMed Web of Science ®Google Scholar
• Kim HK, Cheng AG, Kim HY, Missiakas DM, Schneewind O. Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med 2010; 207:1863 - 70; http://dx.doi.org/10.1084/jem.20092514; PMID: 20713595
   PubMed Web of Science ®Google Scholar
• Kim HK, Thammavongsa V, Schneewind O, Missiakas D. Recurrent infections and immune evasion strategies of Staphylococcus aureus.. Curr Opin Microbiol 2012; 15:92 - 9; http://dx.doi.org/10.1016/j.mib.2011.10.012; PMID: 22088393
   PubMed Web of Science ®Google Scholar
• Proctor RA. Is there a future for a Staphylococcus aureus vaccine?. Vaccine 2012; 30:2921 - 7; http://dx.doi.org/10.1016/j.vaccine.2011.11.006; PMID: 22115633
   PubMed Web of Science ®Google Scholar
• Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 2011; 11:505 - 18; http://dx.doi.org/10.1038/nri3010; PMID: 21720387
   PubMed Web of Science ®Google Scholar
• Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009; 30:108 - 19; http://dx.doi.org/10.1016/j.immuni.2008.11.009; PMID: 19144317
   PubMed Web of Science ®Google Scholar
• Ardura MI, Banchereau R, Mejias A, Di Pucchio T, Glaser C, Allantaz F, et al. Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS One 2009; 4:e5446; http://dx.doi.org/10.1371/journal.pone.0005446; PMID: 19424507
   PubMedGoogle Scholar
• Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008; 226:57 - 79; http://dx.doi.org/10.1111/j.1600-065X.2008.00699.x; PMID: 19161416
   PubMed Web of Science ®Google Scholar
• Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis 2010; 45:246 - 65; http://dx.doi.org/10.1016/j.bcmd.2010.07.012; PMID: 20729109
   PubMed Web of Science ®Google Scholar
• Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 2006; 85:193 - 202; http://dx.doi.org/10.1097/01.md.0000229482.27398.ad; PMID: 16862044
   PubMed Web of Science ®Google Scholar
• Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol 2010; 38:3 - 10; http://dx.doi.org/10.1007/s12016-009-8136-z; PMID: 19504359
   PubMed Web of Science ®Google Scholar
• Kurebayashi Y, Nagai S, Ikejiri A, Koyasu S. Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells. Genes Cells 2013; 18:247 - 65; http://dx.doi.org/10.1111/gtc.12039; PMID: 23383714
   PubMed Web of Science ®Google Scholar
• Kolata J, Bode LG, Holtfreter S, Steil L, Kusch H, Holtfreter B, et al. Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers. Proteomics 2011; 11:3914 - 27; http://dx.doi.org/10.1002/pmic.201000760; PMID: 21805632
   PubMed Web of Science ®Google Scholar
• den Reijer PM, Lemmens-den Toom N, Kant S, Snijders SV, Boelens H, Tavakol M, et al. Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood. PLoS One 2013; 8:e53391; http://dx.doi.org/10.1371/journal.pone.0053391; PMID: 23308212
   PubMed Web of Science ®Google Scholar
• Lin L, Ibrahim AS, Xu X, Farber JM, Avanesian V, Baquir B, et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 2009; 5:e1000703; http://dx.doi.org/10.1371/journal.ppat.1000703; PMID: 20041174
   PubMed Web of Science ®Google Scholar
• Narita K, Hu D-L, Mori F, Wakabayashi K, Iwakura Y, Nakane A. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A. Infect Immun 2010; 78:4234 - 42; http://dx.doi.org/10.1128/IAI.00447-10; PMID: 20679443
   PubMed Web of Science ®Google Scholar
• Yoong P, Pier GB. Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun 2012; 80:2894 - 904; http://dx.doi.org/10.1128/IAI.06360-11; PMID: 22665379
   PubMed Web of Science ®Google Scholar
• Hermos CR, Yoong P, Pier GB. High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection. Clin Infect Dis 2010; 51:1138 - 46; http://dx.doi.org/10.1086/656742; PMID: 20946065
   PubMed Web of Science ®Google Scholar
• Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, Badiou C, et al. Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis 2010; 50:61 - 8; http://dx.doi.org/10.1086/648673; PMID: 19947854
   PubMed Web of Science ®Google Scholar
• Jacobsson G, Colque-Navarro P, Gustafsson E, Andersson R, Möllby R. Antibody responses in patients with invasive Staphylococcus aureus infections. Eur J Clin Microbiol Infect Dis 2010; 29:715 - 25; http://dx.doi.org/10.1007/s10096-010-0919-x; PMID: 20383551
   PubMed Web of Science ®Google Scholar
• Holtfreter S, Jursa-Kulesza J, Masiuk H, Verkaik NJ, de Vogel C, Kolata J, et al. Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus.. Eur J Clin Microbiol Infect Dis 2011; 30:707 - 17; http://dx.doi.org/10.1007/s10096-010-1136-3; PMID: 21509478
   PubMed Web of Science ®Google Scholar
• Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, et al. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J Infect Dis 2012; 206:915 - 23; http://dx.doi.org/10.1093/infdis/jis462; PMID: 22807524
   PubMed Web of Science ®Google Scholar
• Fritz SA, Tiemann KM, Hogan PG, Epplin EK, Rodriguez M, Al-Zubeidi DN, et al. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Clin Infect Dis 2013; 56:1554 - 61; http://dx.doi.org/10.1093/cid/cit123; PMID: 23446627
   PubMed Web of Science ®Google Scholar
• Huang SS, Hinrichsen VL, Datta R, Spurchise L, Miroshnik I, Nelson K, et al. Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection. PLoS One 2011; 6:e24340; http://dx.doi.org/10.1371/journal.pone.0024340; PMID: 21949707
   PubMedGoogle Scholar
• Huang SS, Diekema DJ, Warren DK, Zuccotti G, Winokur PL, Tendolkar S, et al. Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis 2008; 46:1241 - 7; http://dx.doi.org/10.1086/529381; PMID: 18444862
   PubMed Web of Science ®Google Scholar
• Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 2011; 204:937 - 41; http://dx.doi.org/10.1093/infdis/jir441; PMID: 21849291
   PubMed Web of Science ®Google Scholar
• Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus.. Annu Rev Microbiol 2010; 64:143 - 62; http://dx.doi.org/10.1146/annurev.micro.112408.134309; PMID: 20825344
   PubMed Web of Science ®Google Scholar
• Li M, Cheung GY, Hu J, Wang D, Joo HS, Deleo FR, et al. Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains. J Infect Dis 2010; 202:1866 - 76; http://dx.doi.org/10.1086/657419; PMID: 21050125
   PubMed Web of Science ®Google Scholar
• Gauduchon V, Cozon G, Vandenesch F, Genestier AL, Eyssade N, Peyrol S, et al. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 2004; 189:346 - 53; http://dx.doi.org/10.1086/380909; PMID: 14722901
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Seifried S, Zhu L, Srivastava DK, Flynn PM, Shenep JL, et al. Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancer. Pediatr Blood Cancer 2009; 53:1216 - 20; http://dx.doi.org/10.1002/pbc.22254; PMID: 19731325
   PubMed Web of Science ®Google Scholar
• Orscheln RC, Hunstad DA, Fritz SA, Loughman JA, Mitchell K, Storch EK, et al. contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis 2009; 49:536 - 42; http://dx.doi.org/10.1086/600881; PMID: 19589082
   PubMed Web of Science ®Google Scholar
• Bae I-G, Tonthat GT, Stryjewski ME, Rude TH, Reilly LF, Barriere SL, et al. Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol 2009; 47:3952 - 7; http://dx.doi.org/10.1128/JCM.01643-09; PMID: 19846653
   PubMed Web of Science ®Google Scholar
• Yoong P, Pier GB. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc Natl Acad Sci U S A 2010; 107:2241 - 6; http://dx.doi.org/10.1073/pnas.0910344107; PMID: 20133867
   PubMed Web of Science ®Google Scholar
• Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008; 198:1166 - 70; http://dx.doi.org/10.1086/592053; PMID: 18729780
   PubMed Web of Science ®Google Scholar
• Foletti D, Strop P, Shaughnessy L, Hasa-Moreno A, Casas MG, Russell M, et al. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. J Mol Biol 2013; 425:1641 - 54; http://dx.doi.org/10.1016/j.jmb.2013.02.008; PMID: 23416200
   PubMed Web of Science ®Google Scholar
• Gotschlich EC, Goldschneider I, Artenstein MS. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med 1969; 129:1367 - 84; http://dx.doi.org/10.1084/jem.129.6.1367; PMID: 4977283
   PubMed Web of Science ®Google Scholar
• Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969; 129:1327 - 48; http://dx.doi.org/10.1084/jem.129.6.1327; PMID: 4977281
   PubMed Web of Science ®Google Scholar
• Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969; 129:1307 - 26; http://dx.doi.org/10.1084/jem.129.6.1307; PMID: 4977280
   PubMed Web of Science ®Google Scholar
• Gotschlich EC, Goldschneider I, Artenstein MS. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med 1969; 129:1385 - 95; http://dx.doi.org/10.1084/jem.129.6.1385; PMID: 4977284
   PubMed Web of Science ®Google Scholar
• Gold R, Artenstein MS. Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. Bull World Health Organ 1971; 45:279 - 82; PMID: 5316907
   PubMed Web of Science ®Google Scholar
• Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Schneider H, Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med 1970; 282:417 - 20; http://dx.doi.org/10.1056/NEJM197002192820803; PMID: 4983754
   PubMed Web of Science ®Google Scholar
• Weisman LE, Thackray HM, Garcia-Prats JA, Nesin M, Schneider JH, Fretz J, et al. Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates. Antimicrob Agents Chemother 2009; 53:2879 - 86; http://dx.doi.org/10.1128/AAC.01565-08; PMID: 19380597
   PubMed Web of Science ®Google Scholar
• Shinefield HR. Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?. Vaccine 2006; 24:Suppl 2 S2 - 65, 9; http://dx.doi.org/10.1016/j.vaccine.2005.01.126; PMID: 16823932
   PubMedGoogle Scholar
• Vernachio J, Bayer AS, Le T, Chai YL, Prater B, Schneider A, et al. Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob Agents Chemother 2003; 47:3400 - 6; http://dx.doi.org/10.1128/AAC.47.11.3400-3406.2003; PMID: 14576094
   PubMed Web of Science ®Google Scholar
• Joshi A, Pancari G, Cope L, Bowman EP, Cua D, Proctor RA, et al. Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Hum Vaccin Immunother 2012; 8:336 - 46; http://dx.doi.org/10.4161/hv.18946; PMID: 22327491
   PubMed Web of Science ®Google Scholar
• Kim HK, DeDent A, Cheng AG, McAdow M, Bagnoli F, Missiakas DM, et al. IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine 2010; 28:6382 - 92; http://dx.doi.org/10.1016/j.vaccine.2010.02.097; PMID: 20226248
   PubMed Web of Science ®Google Scholar
• Hall AE, Domanski PJ, Patel PR, Vernachio JH, Syribeys PJ, Gorovits EL, et al. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun 2003; 71:6864 - 70; http://dx.doi.org/10.1128/IAI.71.12.6864-6870.2003; PMID: 14638774
   PubMed Web of Science ®Google Scholar
• Brady RA, Mocca CP, Prabhakara R, Plaut RD, Shirtliff ME, Merkel TJ, et al. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection. PLoS One 2013; 8:e63040; http://dx.doi.org/10.1371/journal.pone.0063040; PMID: 23658662
   PubMedGoogle Scholar
• Gening ML, Maira-Litrán T, Kropec A, Skurnik D, Grout M, Tsvetkov YE, et al. Synthetic β-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 2010; 78:764 - 72; http://dx.doi.org/10.1128/IAI.01093-09; PMID: 19948836
   PubMed Web of Science ®Google Scholar
• Maira-Litrán T, Kropec A, Goldmann DA, Pier GB. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-β-(1-6)-glucosamine. Infect Immun 2005; 73:6752 - 62; http://dx.doi.org/10.1128/IAI.73.10.6752-6762.2005; PMID: 16177353
   PubMed Web of Science ®Google Scholar
• Toltzis P, Jacobs MR. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use. Infect Dis Clin North Am 2005; 19:629 - 45; http://dx.doi.org/10.1016/j.idc.2005.05.008; PMID: 16102653
   PubMed Web of Science ®Google Scholar
• Ladhani SN. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom. Clin Ther 2012; 34:385 - 99; http://dx.doi.org/10.1016/j.clinthera.2011.11.027; PMID: 22244051
   PubMed Web of Science ®Google Scholar
• Tan LK, Carlone GM, Borrow R. Advances in the development of vaccines against Neisseria meningitidis.. N Engl J Med 2010; 362:1511 - 20; http://dx.doi.org/10.1056/NEJMra0906357; PMID: 20410516
   PubMed Web of Science ®Google Scholar
• Engels EA, Lau J. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev 2000; CD001261; PMID: 10796623
   PubMedGoogle Scholar
• Cocchiaro JL, Gomez MI, Risley A, Solinga R, Sordelli DO, Lee JC. Molecular characterization of the capsule locus from non-typeable Staphylococcus aureus.. Mol Microbiol 2006; 59:948 - 60; http://dx.doi.org/10.1111/j.1365-2958.2005.04978.x; PMID: 16420363
   PubMed Web of Science ®Google Scholar
• O’Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 2004; 17:218 - 34; http://dx.doi.org/10.1128/CMR.17.1.218-234.2004; PMID: 14726462
   PubMed Web of Science ®Google Scholar
• McKenney D, Pouliot KL, Wang Y, Murthy V, Ulrich M, Döring G, et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 1999; 284:1523 - 7; http://dx.doi.org/10.1126/science.284.5419.1523; PMID: 10348739
   PubMed Web of Science ®Google Scholar
• Maira-Litrán T, Kropec A, Abeygunawardana C, Joyce J, Mark G 3rd, Goldmann DA, et al. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun 2002; 70:4433 - 40; http://dx.doi.org/10.1128/IAI.70.8.4433-4440.2002; PMID: 12117954
   PubMed Web of Science ®Google Scholar
• Sutter DE, Summers AM, Keys CE, Taylor KL, Frasch CE, Braun LE, et al. Capsular serotype of Staphylococcus aureus in the era of community-acquired MRSA. FEMS Immunol Med Microbiol 2011; 63:16 - 24; http://dx.doi.org/10.1111/j.1574-695X.2011.00822.x; PMID: 21631600
   PubMed Web of Science ®Google Scholar
• Melles DC, Taylor KL, Fattom AI, van Belkum A. Serotyping of Dutch Staphylococcus aureus strains from carriage and infection. FEMS Immunol Med Microbiol 2008; 52:287 - 92; http://dx.doi.org/10.1111/j.1574-695X.2008.00376.x; PMID: 18218024
   PubMed Web of Science ®Google Scholar
• von Eiff C, Taylor KL, Mellmann A, Fattom AI, Friedrich AW, Peters G, et al. Distribution of capsular and surface polysaccharide serotypes of Staphylococcus aureus.. Diagn Microbiol Infect Dis 2007; 58:297 - 302; http://dx.doi.org/10.1016/j.diagmicrobio.2007.01.016; PMID: 17376630
   PubMed Web of Science ®Google Scholar
• Verdier I, Durand G, Bes M, Taylor KL, Lina G, Vandenesch F, et al. Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests. J Clin Microbiol 2007; 45:725 - 9; http://dx.doi.org/10.1128/JCM.01572-06; PMID: 17202275
   PubMed Web of Science ®Google Scholar
• Fattom A, Schneerson R, Watson DC, Karakawa WW, Fitzgerald D, Pastan I, et al. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. Infect Immun 1993; 61:1023 - 32; PMID: 8432585
   PubMed Web of Science ®Google Scholar
• Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346:491 - 6; http://dx.doi.org/10.1056/NEJMoa011297; PMID: 11844850
   PubMed Web of Science ®Google Scholar
• Fattom A, Fuller S, Propst M, Winston S, Muenz L, He D, et al. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 2004; 23:656 - 63; http://dx.doi.org/10.1016/j.vaccine.2004.06.043; PMID: 15542186
   PubMed Web of Science ®Google Scholar
• Hudson LO, Murphy CR, Spratt BG, Enright MC, Elkins K, Nguyen C, et al. Diversity of methicillin-resistant Staphylococcus aureus(MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California. PLoS One 2013; 8:e62117; http://dx.doi.org/10.1371/journal.pone.0062117; PMID: 23637976
   PubMedGoogle Scholar
• Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J, et al. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 2008; 198:561 - 70; http://dx.doi.org/10.1086/590157; PMID: 18598194
   PubMed Web of Science ®Google Scholar
• Shopsin B, Eaton C, Wasserman GA, Mathema B, Adhikari RP, Agolory S, et al. Mutations in agr do not persist in natural populations of methicillin-resistant Staphylococcus aureus.. J Infect Dis 2010; 202:1593 - 9; http://dx.doi.org/10.1086/656915; PMID: 20942648
   PubMed Web of Science ®Google Scholar
• Traber KE, Lee E, Benson S, Corrigan R, Cantera M, Shopsin B, et al. agr function in clinical Staphylococcus aureus isolates. Microbiology 2008; 154:2265 - 74; http://dx.doi.org/10.1099/mic.0.2007/011874-0; PMID: 18667559
   PubMed Web of Science ®Google Scholar
• Shopsin B, Drlica-Wagner A, Mathema B, Adhikari RP, Kreiswirth BN, Novick RP. Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J Infect Dis 2008; 198:1171 - 4; http://dx.doi.org/10.1086/592051; PMID: 18752431
   PubMed Web of Science ®Google Scholar
• Smyth DS, Kafer JM, Wasserman GA, Velickovic L, Mathema B, Holzman RS, et al. Nasal carriage as a source of agr-defective Staphylococcus aureus bacteremia. J Infect Dis 2012; 206:1168 - 77; http://dx.doi.org/10.1093/infdis/jis483; PMID: 22859823
   PubMed Web of Science ®Google Scholar
• Luong T, Sau S, Gomez M, Lee JC, Lee CY. Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA. Infect Immun 2002; 70:444 - 50; http://dx.doi.org/10.1128/IAI.70.2.444-450.2002; PMID: 11796569
   PubMed Web of Science ®Google Scholar
• Pozzi C, Wilk K, Lee JC, Gening M, Nifantiev N, Pier GB. Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens. PLoS One 2012; 7:e46648; http://dx.doi.org/10.1371/journal.pone.0046648; PMID: 23077517
   PubMed Web of Science ®Google Scholar
• Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O’Malley JM, Cywes-Bentley C, Pier GB. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A. PLoS One 2012; 7:e43813; http://dx.doi.org/10.1371/journal.pone.0043813; PMID: 22970144
   PubMedGoogle Scholar
• Kelly-Quintos C, Cavacini LA, Posner MR, Goldmann D, Pier GB. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun 2006; 74:2742 - 50; http://dx.doi.org/10.1128/IAI.74.5.2742-2750.2006; PMID: 16622211
   PubMed Web of Science ®Google Scholar
• Kropec A, Maira-Litran T, Jefferson KK, Grout M, Cramton SE, Götz F, et al. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun 2005; 73:6868 - 76; http://dx.doi.org/10.1128/IAI.73.10.6868-6876.2005; PMID: 16177366
   PubMed Web of Science ®Google Scholar
• Joyce JG, Abeygunawardana C, Xu Q, Cook JC, Hepler R, Przysiecki CT, et al. Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus.. Carbohydr Res 2003; 338:903 - 22; http://dx.doi.org/10.1016/S0008-6215(03)00045-4; PMID: 12681914
   PubMed Web of Science ®Google Scholar
• Cerca N, Jefferson KK, Maira-Litrán T, Pier DB, Kelly-Quintos C, Goldmann DA, et al. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-β-(1-6)-glucosamine. Infect Immun 2007; 75:3406 - 13; http://dx.doi.org/10.1128/IAI.00078-07; PMID: 17470540
   PubMed Web of Science ®Google Scholar
• Vlock D, Lee JC, Kropec-Huebner A, Pier GB. Pre-clinical and initial phase I evaluations of a fully human monoclonal antibody directed against the PNAG surface polysaccharide on Staphylococcus aureus. Abstracts of the 50th ICAAC 2010; Abstract G1-1654/329 2010.
   Google Scholar
• Wang X, Preston JF 3rd, Romeo T. The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol 2004; 186:2724 - 34; http://dx.doi.org/10.1128/JB.186.9.2724-2734.2004; PMID: 15090514
   PubMed Web of Science ®Google Scholar
• Parise G, Mishra M, Itoh Y, Romeo T, Deora R. Role of a putative polysaccharide locus in Bordetella biofilm development. J Bacteriol 2007; 189:750 - 60; http://dx.doi.org/10.1128/JB.00953-06; PMID: 17114249
   PubMed Web of Science ®Google Scholar
• Cerca N, Maira-Litrán T, Jefferson KK, Grout M, Goldmann DA, Pier GB. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci U S A 2007; 104:7528 - 33; http://dx.doi.org/10.1073/pnas.0700630104; PMID: 17446272
   PubMed Web of Science ®Google Scholar
• Izano EA, Sadovskaya I, Vinogradov E, Mulks MH, Velliyagounder K, Ragunath C, et al. Poly-N-acetylglucosamine mediates biofilm formation and antibiotic resistance in Actinobacillus pleuropneumoniae.. Microb Pathog 2007; 43:1 - 9; http://dx.doi.org/10.1016/j.micpath.2007.02.004; PMID: 17412552
   PubMed Web of Science ®Google Scholar
• Skurnik D, Davis MR Jr., Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, et al. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. J Infect Dis 2012; 205:1709 - 18; http://dx.doi.org/10.1093/infdis/jis254; PMID: 22448004
   PubMed Web of Science ®Google Scholar
• Cywes-Bentley C, Skurnik D, Zaidi T, Roux D, Deoliveira RB, Garrett WS, et al. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci U S A 2013; 110:E2209 - 18; http://dx.doi.org/10.1073/pnas.1303573110; PMID: 23716675
   PubMed Web of Science ®Google Scholar
• Fitzgerald SF, O’Gorman J, Morris-Downes MM, Crowley RK, Donlon S, Bajwa R, et al. A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done. J Hosp Infect 2011; 79:218 - 21; http://dx.doi.org/10.1016/j.jhin.2011.06.015; PMID: 21856042
   PubMed Web of Science ®Google Scholar
• DeJonge M, Burchfield D, Bloom B, Duenas M, Walker W, Polak M, et al. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 2007; 151:260 - 5, e1; http://dx.doi.org/10.1016/j.jpeds.2007.04.060; PMID: 17719934
   PubMed Web of Science ®Google Scholar
• Weisman LE, Thackray HM, Steinhorn RH, Walsh WF, Lassiter HA, Dhanireddy R, et al. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics 2011; 128:271 - 9; http://dx.doi.org/10.1542/peds.2010-3081; PMID: 21788224
   PubMed Web of Science ®Google Scholar
• Pahys JM, Pahys JR, Cho SK, Kang MM, Zebala LP, Hawasli AH, et al. Methods to decrease postoperative infections following posterior cervical spine surgery. J Bone Joint Surg Am 2013; 95:549 - 54; http://dx.doi.org/10.2106/JBJS.K.00756; PMID: 23515990
   PubMed Web of Science ®Google Scholar
• Fry DE. The continued challenge of Staphylococcus aureus in the surgical patient. Am Surg 2013; 79:1 - 10; PMID: 23317583
   PubMed Web of Science ®Google Scholar
• Goyal N, Miller A, Tripathi M, Parvizi J. Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening. Bone Joint J 2013; 95-B:4 - 9; http://dx.doi.org/10.1302/0301-620X.95B1.27973; PMID: 23307666
   PubMed Web of Science ®Google Scholar
• Marshall C, Richards M, McBryde E. Do active surveillance and contact precautions reduce MRSA acquisition? A prospective interrupted time series. PLoS One 2013; 8:e58112; http://dx.doi.org/10.1371/journal.pone.0058112; PMID: 23555568
   PubMed Web of Science ®Google Scholar
• Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368:533 - 42; http://dx.doi.org/10.1056/NEJMoa1113849; PMID: 23388005
   PubMed Web of Science ®Google Scholar
• Stranger-Jones YK, Bae T, Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus.. Proc Natl Acad Sci U S A 2006; 103:16942 - 7; http://dx.doi.org/10.1073/pnas.0606863103; PMID: 17075065
   PubMed Web of Science ®Google Scholar
• Tsuji T, Shimizu T, Sasaki K, Tsukamoto K, Arimitsu H, Ochi S, et al. A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2. Vaccine 2008; 26:2092 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.02.034; PMID: 18387720
   PubMed Web of Science ®Google Scholar
• Serna A 4th, Boedeker EC. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 2008; 24:38 - 47; http://dx.doi.org/10.1097/MOG.0b013e3282f2dfb8; PMID: 18043231
   PubMed Web of Science ®Google Scholar
• Gerding DN. Clostridium difficile infection prevention: biotherapeutics, immunologics, and vaccines. Discov Med 2012; 13:75 - 83; PMID: 22284786
   PubMedGoogle Scholar